First Time Loading...

Neurotech International Ltd
ASX:NTI

Watchlist Manager
Neurotech International Ltd Logo
Neurotech International Ltd
ASX:NTI
Watchlist
Price: 0.09 AUD Market Closed
Updated: Apr 29, 2024

Intrinsic Value

NTI's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions... [ Read More ]

The intrinsic value of one NTI stock under the Base Case scenario is 0.01 AUD. Compared to the current market price of 0.09 AUD, Neurotech International Ltd is Overvalued by 93%.

Key Points:
NTI Intrinsic Value
Base Case
0.01 AUD
Overvaluation 93%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Neurotech International Ltd

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NTI stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Neurotech International Ltd

Provide an overview of the primary business activities
of Neurotech International Ltd.

What unique competitive advantages
does Neurotech International Ltd hold over its rivals?

What risks and challenges
does Neurotech International Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Neurotech International Ltd.

Provide P/S
for Neurotech International Ltd.

Provide P/E
for Neurotech International Ltd.

Provide P/OCF
for Neurotech International Ltd.

Provide P/FCFE
for Neurotech International Ltd.

Provide P/B
for Neurotech International Ltd.

Provide EV/S
for Neurotech International Ltd.

Provide EV/GP
for Neurotech International Ltd.

Provide EV/EBITDA
for Neurotech International Ltd.

Provide EV/EBIT
for Neurotech International Ltd.

Provide EV/OCF
for Neurotech International Ltd.

Provide EV/FCFF
for Neurotech International Ltd.

Provide EV/IC
for Neurotech International Ltd.

Compare the intrinsic valuations
of Neurotech International Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Neurotech International Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Neurotech International Ltd compared to its peers.

Compare the P/E ratios
of Neurotech International Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Neurotech International Ltd with its peers.

Analyze the financial leverage
of Neurotech International Ltd compared to its main competitors.

Show all profitability ratios
for Neurotech International Ltd.

Provide ROE
for Neurotech International Ltd.

Provide ROA
for Neurotech International Ltd.

Provide ROIC
for Neurotech International Ltd.

Provide ROCE
for Neurotech International Ltd.

Provide Gross Margin
for Neurotech International Ltd.

Provide Operating Margin
for Neurotech International Ltd.

Provide Net Margin
for Neurotech International Ltd.

Provide FCF Margin
for Neurotech International Ltd.

Show all solvency ratios
for Neurotech International Ltd.

Provide D/E Ratio
for Neurotech International Ltd.

Provide D/A Ratio
for Neurotech International Ltd.

Provide Interest Coverage Ratio
for Neurotech International Ltd.

Provide Altman Z-Score Ratio
for Neurotech International Ltd.

Provide Quick Ratio
for Neurotech International Ltd.

Provide Current Ratio
for Neurotech International Ltd.

Provide Cash Ratio
for Neurotech International Ltd.

What is the historical Revenue growth
over the last 5 years for Neurotech International Ltd?

What is the historical Net Income growth
over the last 5 years for Neurotech International Ltd?

What is the current Free Cash Flow
of Neurotech International Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Neurotech International Ltd.

Financials

Balance Sheet Decomposition
Neurotech International Ltd

Current Assets 5.3m
Cash & Short-Term Investments 5m
Receivables 257.6k
Other Current Assets 24.6k
Non-Current Assets 870
PP&E 870
Current Liabilities 1.3m
Accounts Payable 1.3m
Efficiency

Earnings Waterfall
Neurotech International Ltd

Revenue
1.3m AUD
Cost of Revenue
0 AUD
Gross Profit
1.3m AUD
Operating Expenses
-9m AUD
Operating Income
-7.8m AUD
Other Expenses
0 AUD
Net Income
-7.8m AUD

Free Cash Flow Analysis
Neurotech International Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NTI Profitability Score
Profitability Due Diligence

Neurotech International Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Exceptional 3-Years Revenue Growth
Positive Gross Profit
Exceptional ROIC
50/100
Profitability
Score

Neurotech International Ltd's profitability score is 50/100. The higher the profitability score, the more profitable the company is.

NTI Solvency Score
Solvency Due Diligence

Neurotech International Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Short-Term Solvency
Average Altman Z-Score
71/100
Solvency
Score

Neurotech International Ltd's solvency score is 71/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NTI Price Targets Summary
Neurotech International Ltd

There are no price targets for NTI.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NTI Price
Neurotech International Ltd

1M 1M
-14%
6M 6M
+55%
1Y 1Y
+80%
3Y 3Y
+45%
5Y 5Y
+309%
10Y 10Y
-64%
Annual Price Range
0.09
52w Low
0.033
52w High
0.12
Price Metrics
Average Annual Return 49.69%
Standard Deviation of Annual Returns 83.79%
Max Drawdown -89%
Shares Statistics
Market Capitalization 78.7m AUD
Shares Outstanding 917 388 992
Percentage of Shares Shorted
N/A

NTI Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Neurotech International Ltd Logo
Neurotech International Ltd

Country

Australia

Industry

Health Care

Market Cap

78.7m AUD

Dividend Yield

0%

Description

Neurotech International Ltd. engages in the research, designing, marketing, and through third party manufacturers, production of wearable neurotechnology devices to assist with neurological conditions such as autism. The company is headquartered in Nedlands, Western Australia. The company went IPO on 2016-11-04. The firm operates through its wholly owned, Malta-based subsidiary AAT Research Limited. The firm is focusing on neuro-protective, anti-inflammatory and neuro-modulatory activities of NTI/Dolce cannabis strains. The firm through its class II device Mente is focused on development and commercialisation of technological solutions for the screening and treatment of symptoms associated with conditions such as autism. Mente is, a home therapy that is clinically proven to increase engagement and relaxation in autistic children with elevated Delta band brain activity.

Contact

WESTERN AUSTRALIA
Nedlands
Cpc, U 5 145 Stirling Hwy
+61893893130.0
http://neurotechinternational.com/

IPO

2016-11-04

Employees

-

Officers

Chief Operating Officer
Dr. Alexandra Andrews
Director of Public Relations & Director
Mr. Gerald Quigley
Executive Director
Dr. Thomas Duthy M.B.A., Ph.D.
Chief Scientific Officer & Member of Scientific Advisory Board
Dr. Emanuela Russo
Chief Executive Officer of AAT Research Ltd
Mr. Peter James Lawrence Griffiths B.Sc.
Company Secretary
Ms. Erlyn Saromines Dawson A.C.I.S., ACIS, AGIA, B.Com., BCom., GradDipACG

See Also

Discover More
What is the Intrinsic Value of one NTI stock?

The intrinsic value of one NTI stock under the Base Case scenario is 0.01 AUD.

Is NTI stock undervalued or overvalued?

Compared to the current market price of 0.09 AUD, Neurotech International Ltd is Overvalued by 93%.